or Try an Advanced Search...

    Technical Analysis for AVIR - Atea Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 3.29 1.54% 0.05
    AVIR closed up 1.54 percent on Friday, November 1, 2024, on 42 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: Nov 6
    *** please verify all earnings dates ***
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical AVIR trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    NR7-2 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Gapped Up Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    NR7 Range Contraction 1.54%
    Down 3 Days in a Row Weakness 1.54%
    Oversold Stochastic Weakness 1.54%
    Outside Day Range Expansion 0.30%
    Gapped Up Strength 0.30%
    Older End-of-Day Signals for AVIR ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 19 hours ago
    Rose Above Previous Day's High about 20 hours ago
    Up 2% about 20 hours ago
    60 Minute Opening Range Breakout about 22 hours ago
    Gap Up Partially Closed about 24 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    AVIR Chart by TradingView
    Basic chart:

    Profile

    Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology

    Is AVIR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 31 Atea Pharmaceuticals to Host Third Quarter 2024 Financial Results Conference Call on November 7, 2024
    Oct 30 Atea Pharmaceuticals to Present New Data Supporting the Combination of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at AASLD’s The Liver Meeting 2024
    Oct 21 Atea Pharmaceuticals Leads The Charge In US Penny Stocks Spotlight
    Oct 16 ZBH Gears Up for Q3 Earnings: What Lies Ahead for the Stock?
    Oct 9 Atea Pharmaceuticals Inc (AVIR) Q2 2024 Earnings Call Highlights: Strong Financial Position and ...
    Oct 4 Atea Pharmaceuticals (AVIR) Loses -8.01% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
    Sep 13 Atea Pharmaceuticals' COVID-19 Treatment Flunks In Late-Stage Study, Blames 'Constantly Evolving' Virus
    Sep 13 Atea stock drops as COVID-19 therapy fails in late-stage trial
    Sep 13 Atea Pharmaceuticals Provides Update on Global Phase 3 SUNRISE-3 Trial Evaluating Bemnifosbuvir for Treatment of COVID-19
    Aug 28 Are Medical Stocks Lagging Atea Pharmaceuticals (AVIR) This Year?
    See more AVIR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.6
    52 Week Low 2.765
    Average Volume 188,591
    200-Day Moving Average 3.74
    50-Day Moving Average 3.58
    20-Day Moving Average 3.47
    10-Day Moving Average 3.40
    Average True Range 0.13
    RSI (14) 40.48
    ADX 17.3
    +DI 15.52
    -DI 25.57
    Chandelier Exit (Long, 3 ATRs) 3.46
    Chandelier Exit (Short, 3 ATRs) 3.62
    Upper Bollinger Bands 3.79
    Lower Bollinger Band 3.16
    Percent B (%b) 0.21
    BandWidth 18.12
    MACD Line -0.07
    MACD Signal Line -0.04
    MACD Histogram -0.0269
    Fundamentals Value
    Market Cap 274.5 Million
    Num Shares 83.4 Million
    EPS -1.57
    Price-to-Earnings (P/E) Ratio -2.10
    Price-to-Sales 1.90
    Price-to-Book 0.61
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.39
    Resistance 3 (R3) 3.38 3.35 3.37
    Resistance 2 (R2) 3.35 3.32 3.35 3.36
    Resistance 1 (R1) 3.32 3.31 3.33 3.32 3.36
    Pivot Point 3.28 3.28 3.29 3.28 3.28
    Support 1 (S1) 3.25 3.26 3.27 3.26 3.22
    Support 2 (S2) 3.22 3.24 3.22 3.22
    Support 3 (S3) 3.19 3.22 3.21
    Support 4 (S4) 3.19